Degenerative Disc Disease

Oncology·MeSH: Intervertebral Disc Degeneration

7 drugs in development·4 companies·23 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Phase 1(2)

Drug	Company
AlloStemSpine® (CELZ-201 ADAPT)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
AlloStemSpine® Chronic Lower Back Pain (CELZ-201 ADAPT)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

Unknown(1)

Drug	Company
natural matrix protein fibers	HCW Biologics Inc. (HCWB)

N/A(1)

Drug	Company
StemSpine®	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)

BioSniper tracks 7 drugs in development for Degenerative Disc Disease across 4 companies.

There are 23 clinical trials targeting Degenerative Disc Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.